-
1
-
-
33749632375
-
The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma
-
E. Giné, S. Montoto, F. Bosch, L. Arenillas, S. Mercadal, and N. Villamor et al. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma Ann Oncol 17 10 2006 1539 1545
-
(2006)
Ann Oncol
, vol.17
, Issue.10
, pp. 1539-1545
-
-
Giné, E.1
Montoto, S.2
Bosch, F.3
Arenillas, L.4
Mercadal, S.5
Villamor, N.6
-
2
-
-
79960116662
-
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
-
R.O. Casasnovas, M. Meignan, A. Berriolo-Riedinger, S. Bardet, A. Julian, and C. Thieblemont et al. SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma Blood 118 1 2011 37 43
-
(2011)
Blood
, vol.118
, Issue.1
, pp. 37-43
-
-
Casasnovas, R.O.1
Meignan, M.2
Berriolo-Riedinger, A.3
Bardet, S.4
Julian, A.5
Thieblemont, C.6
-
3
-
-
63849205243
-
Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy
-
E. Itti, C. Lin, J. Dupuis, G. Paone, D. Capacchione, and A. Rahmouni et al. Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy J Nucl Med 50 4 2009 527 533
-
(2009)
J Nucl Med
, vol.50
, Issue.4
, pp. 527-533
-
-
Itti, E.1
Lin, C.2
Dupuis, J.3
Paone, G.4
Capacchione, D.5
Rahmouni, A.6
-
4
-
-
34548587491
-
Overview of early response assessment in lymphoma with FDG-PET
-
M.P. MacManus, J.F. Seymour, and R.J. Hicks Overview of early response assessment in lymphoma with FDG-PET Cancer Imaging 7 2007 10 18
-
(2007)
Cancer Imaging
, vol.7
, pp. 10-18
-
-
Macmanus, M.P.1
Seymour, J.F.2
Hicks, R.J.3
-
5
-
-
1842529563
-
Application of dynamic contrast-enhanced MRI to differentiate malignant lymphoma from squamous cell carcinoma in the head and neck
-
J. Asaumi, Y. Yanagi, H. Konouchi, M. Hisatomi, H. Matsuzaki, and K. Kishi Application of dynamic contrast-enhanced MRI to differentiate malignant lymphoma from squamous cell carcinoma in the head and neck Oral Oncol 40 6 2004 579 584
-
(2004)
Oral Oncol
, vol.40
, Issue.6
, pp. 579-584
-
-
Asaumi, J.1
Yanagi, Y.2
Konouchi, H.3
Hisatomi, M.4
Matsuzaki, H.5
Kishi, K.6
-
6
-
-
0034997733
-
Mediastinal lymphoma: Quantitative changes in gadolinium enhancement at mr imaging after treatment
-
Alain Rahmouni, Marine Divine, Eric Lepage, N. Jazaerli, K. Belhadj, and P. Gaulard et al. Mediastinal lymphoma: quantitative changes in gadolinium enhancement at mr imaging after treatment Radiology 219 2001 621 628
-
(2001)
Radiology
, vol.219
, pp. 621-628
-
-
Rahmouni, A.1
Divine, M.2
Lepage, E.3
Jazaerli, N.4
Belhadj, K.5
Gaulard, P.6
-
7
-
-
0345446717
-
Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: Dynamic gadolinium-enhanced MR imaging
-
Alain Rahmouni, Jean-Luc Montazel, Marine Divine, E. Lepage, K. Belhadj, and P. Gaulard et al. Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging Radiology 229 2003 710 717
-
(2003)
Radiology
, vol.229
, pp. 710-717
-
-
Rahmouni, A.1
Montazel, J.2
Divine, M.3
Lepage, E.4
Belhadj, K.5
Gaulard, P.6
-
8
-
-
84899966595
-
Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in hodgkin lymphoma patients
-
(February) [Epub ahead of print]
-
Rossi C, Kanoun S, Berriolo-Riedinger A, Dygai-Cochet I, Humbert O, Legouge C, et al. Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in hodgkin lymphoma patients. J Nucl Med 2014;(February) [Epub ahead of print].
-
(2014)
J Nucl Med
-
-
Rossi, C.1
Kanoun, S.2
Berriolo-Riedinger, A.3
Dygai-Cochet, I.4
Humbert, O.5
Legouge, C.6
-
9
-
-
80052213872
-
Whole-body diffusion-weighted imaging: The added value to whole-body MRI at initial diagnosis of lymphoma
-
J. Gu, T. Chan, J. Zhang, A.Y. Leung, Y.L. Kwong, and P.L. Khong Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma AJR Am J Roentgenol 197 3 2011 W384 W391
-
(2011)
AJR Am J Roentgenol
, vol.197
, Issue.3
-
-
Gu, J.1
Chan, T.2
Zhang, J.3
Leung, A.Y.4
Kwong, Y.L.5
Khong, P.L.6
-
10
-
-
79958843357
-
Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients
-
G. Abdulqadhr, D. Molin, G. Aström, M. Suurküla, L. Johansson, and H. Hagberg et al. Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients Acta Radiol 52 2 2011 173 180
-
(2011)
Acta Radiol
, vol.52
, Issue.2
, pp. 173-180
-
-
Abdulqadhr, G.1
Molin, D.2
Aström, G.3
Suurküla, M.4
Johansson, L.5
Hagberg, H.6
-
11
-
-
79954829586
-
Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: Pilot study
-
C. Lin, E. Itti, A. Luciani, B. Zegai, S.J. Lin, and F. Kuhnowski et al. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study Invest Radiol 46 5 2011 341 349
-
(2011)
Invest Radiol
, vol.46
, Issue.5
, pp. 341-349
-
-
Lin, C.1
Itti, E.2
Luciani, A.3
Zegai, B.4
Lin, S.J.5
Kuhnowski, F.6
-
12
-
-
0343239071
-
Response criteria for NHL: Importance of 'normal' lymph node size and correlations with response rates
-
A.J. Grillo-López, B.D. Cheson, S.J. Horning, B.A. Peterson, W.D. Carter, and C.L. Varns et al. Response criteria for NHL: importance of 'normal' lymph node size and correlations with response rates Ann Oncol 11 4 2000 399 408
-
(2000)
Ann Oncol
, vol.11
, Issue.4
, pp. 399-408
-
-
Grillo-López, A.J.1
Cheson, B.D.2
Horning, S.J.3
Peterson, B.A.4
Carter, W.D.5
Varns, C.L.6
-
13
-
-
33947496614
-
Revised response criteria for malignant lymphoma
-
B.D. Cheson, B. Pfistner, M.E. Juweid, R.D. Gascoyne, L. Specht, and S.J. Horning et al. Revised response criteria for malignant lymphoma J Clin Oncol 25 2007 579586
-
(2007)
J Clin Oncol
, vol.25
, pp. 579586
-
-
Cheson, B.D.1
Pfistner, B.2
Juweid, M.E.3
Gascoyne, R.D.4
Specht, L.5
Horning, S.J.6
-
14
-
-
79957497589
-
Dose-escalation with beacopp escalated is superior to ABVD in the combined-modality treatment of early unfavorable hodgkin lymphoma: Final analysis of the German Hodgkin Study Group (GHSG) HD14 Trial
-
[Abstract 765]
-
Engert A, Borchmann P, Pluetschow A, et al. Dose-escalation with beacopp escalated is superior to ABVD in the combined-modality treatment of early unfavorable hodgkin lymphoma: final analysis of the German Hodgkin Study Group (GHSG) HD14 Trial. Blood (ASH Annual Meeting Abstracts) 2010;116 [Abstract 765].
-
(2010)
Blood (ASH Annual Meeting Abstracts)
, vol.116
-
-
Engert, A.1
Borchmann, P.2
Pluetschow, A.3
-
15
-
-
77952477025
-
Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era
-
M. Ziepert, D. Hasenclever, E. Kuhnt, B. Glass, N. Schmitz, and M. Pfreundschuh et al. Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era J Clin Oncol 28 14 2010 2373 2380
-
(2010)
J Clin Oncol
, vol.28
, Issue.14
, pp. 2373-2380
-
-
Ziepert, M.1
Hasenclever, D.2
Kuhnt, E.3
Glass, B.4
Schmitz, N.5
Pfreundschuh, M.6
-
16
-
-
0027731029
-
Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography
-
O.S. Hoekstra, A. van Lingen, G.J. Ossenkoppele, R. Golding, and G.J. Teule Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography Eur J Nucl Med 20 12 1993 1214 1217
-
(1993)
Eur J Nucl Med
, vol.20
, Issue.12
, pp. 1214-1217
-
-
Hoekstra, O.S.1
Van Lingen, A.2
Ossenkoppele, G.J.3
Golding, R.4
Teule, G.J.5
-
17
-
-
80052213872
-
Whole-body diffusion-weighted imaging: The added value to whole-body MRI at initial diagnosis of lymphoma
-
H.M. van Ufford, T.C. Kwee, F.J. Beek, T. Takahara, C.S. Uiterwaal, and M.B. Bierings et al. Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma AJR Am J Roentgenol 197 3 2011 W384 W391
-
(2011)
AJR Am J Roentgenol
, vol.197
, Issue.3
-
-
Van Ufford, H.M.1
Kwee, T.C.2
Beek, F.J.3
Takahara, T.4
Uiterwaal, C.S.5
Bierings, M.B.6
-
18
-
-
84860611221
-
Whole-body MR-DWIBS vs. [(18)F]-FDG-PET/CT in the study of malignant tumors: A retrospective study
-
(July) [Epub ahead of print]
-
Cafagna D, Rubini G, Iuele F, Maggialetti N, Notaristefano A, Pinto D, et al. Whole-body MR-DWIBS vs. [(18)F]-FDG-PET/CT in the study of malignant tumors: a retrospective study. Radiol Med 2011;(July) [Epub ahead of print].
-
(2011)
Radiol Med
-
-
Cafagna, D.1
Rubini, G.2
Iuele, F.3
Maggialetti, N.4
Notaristefano, A.5
Pinto, D.6
-
19
-
-
59849091285
-
Monitoring response to chemotherapy of non-Hodgkin's lymphoma xenografts by T(2)-weighted and diffusion-weighted MRI
-
M.Q. Huang, S. Pickup, D.S. Nelson, H. Qiao, H.N. Xu, and L.Z. Li et al. Monitoring response to chemotherapy of non-Hodgkin's lymphoma xenografts by T(2)-weighted and diffusion-weighted MRI NMR Biomed 21 10 2008 1021 1029
-
(2008)
NMR Biomed
, vol.21
, Issue.10
, pp. 1021-1029
-
-
Huang, M.Q.1
Pickup, S.2
Nelson, D.S.3
Qiao, H.4
Xu, H.N.5
Li, L.Z.6
-
20
-
-
79960485182
-
Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: Preliminary results
-
M. Horger, K. Weisel, W. Horger, A. Mroue, M. Fenchel, and M. Lichy Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results AJR Am J Roentgenol 196 6 2011 W790 W795
-
(2011)
AJR Am J Roentgenol
, vol.196
, Issue.6
-
-
Horger, M.1
Weisel, K.2
Horger, W.3
Mroue, A.4
Fenchel, M.5
Lichy, M.6
-
21
-
-
2642613656
-
Positron emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose
-
W. Römer, A.R. Hanauske, S. Ziegler, R. Thödtmann, W. Weber, and C. Fuchs et al. Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose Blood 91 12 1998 4464 4471
-
(1998)
Blood
, vol.91
, Issue.12
, pp. 4464-4471
-
-
Römer, W.1
Hanauske, A.R.2
Ziegler, S.3
Thödtmann, R.4
Weber, W.5
Fuchs, C.6
-
22
-
-
0027363708
-
Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy
-
O.S. Hoekstra, G.J. Ossenkoeppele, R. Golding, A. van Lingen, G.W. Visser, and G.J. Teule et al. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy J Nucl Med 34 1993 1706 1710
-
(1993)
J Nucl Med
, vol.34
, pp. 1706-1710
-
-
Hoekstra, O.S.1
Ossenkoeppele, G.J.2
Golding, R.3
Van Lingen, A.4
Visser, G.W.5
Teule, G.J.6
-
23
-
-
0027442958
-
Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: Initial evaluation
-
R.L. Wahl, K. Zasadny, M. Helvie, G.D. Hutchins, B. Weber, and R. Cody Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation J Clin Oncol 11 11 1993 2101 2111
-
(1993)
J Clin Oncol
, vol.11
, Issue.11
, pp. 2101-2111
-
-
Wahl, R.L.1
Zasadny, K.2
Helvie, M.3
Hutchins, G.D.4
Weber, B.5
Cody, R.6
-
24
-
-
84882250460
-
Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma - A whole-body MRI and diffusion-weighted imaging study
-
(March) doi:10.1002/nbm.2933 [Epub ahead of print]
-
Wu WE, Nerisho S, Dastidar P, Ryymin P, Järvenpää R, Pertovaara H, et al. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma - a whole-body MRI and diffusion-weighted imaging study. NMR Biomed 2013;(March) doi:10.1002/nbm.2933 [Epub ahead of print].
-
(2013)
NMR Biomed
-
-
Wu We, N.1
-
25
-
-
34547402187
-
Diffusion and perfusion imaging in subacute neurotoxicity following high-dose methotrexate
-
A.F. Eichler, T.T. Batchelor, and J.W. Henson Diffusion and perfusion imaging in subacute neurotoxicity following high-dose methotrexate Neuro Oncol 9 3 2007 373 377
-
(2007)
Neuro Oncol
, vol.9
, Issue.3
, pp. 373-377
-
-
Eichler, A.F.1
Batchelor, T.T.2
Henson, J.W.3
-
26
-
-
70349680664
-
Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: Initial results
-
C. Schraml, N.F. Schwenzer, P. Martirosian, M. Bitzer, U. Lauer, and C.D. Claussen et al. Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results AJR Am J Roentgenol 193 4 2009 W301 W307
-
(2009)
AJR Am J Roentgenol
, vol.193
, Issue.4
-
-
Schraml, C.1
Schwenzer, N.F.2
Martirosian, P.3
Bitzer, M.4
Lauer, U.5
Claussen, C.D.6
-
27
-
-
61349123591
-
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: Consensus and recommendations
-
A.R. Padhani, G. Liu, D.M. Koh, T.L. Chenevert, H.C. Thoeny, and T. Takahara et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations Neoplasia 11 2 2009 102 125
-
(2009)
Neoplasia
, vol.11
, Issue.2
, pp. 102-125
-
-
Padhani, A.R.1
Liu, G.2
Koh, D.M.3
Chenevert, T.L.4
Thoeny, H.C.5
Takahara, T.6
|